Actinium Pharmaceuticals, Inc. (ATNM)

1.31 +0.03 (+2.34%) USD  |  NYAM  |  Jan 21, 11:34
More

Actinium Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Assertio Holdings, Inc. Upgrade
Altimmune, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Avanos Medical, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade